Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
2,470
datasets available to search
ShareScore release 0.9.0
Dataset results
2,470 results for “Acute Myeloid Leukemia”
A Safety, Tolerability and Preliminary Efficacy Study of CC-90011 in Combination With Venetoclax and Azacitidine in R/R Acute Myeloid Leukemia and Treatment-naïve Participants Not Eligible for Intensi
ClinicalTrials.gov study NCT04748848. IPD Sharing: YES. Countries: 4. Publications: 0.
Venetoclax in Combination With Decitabine and Cedazuridine for the Treatment of Relapsed or Refractory Acute Myeloid Leukemia
ClinicalTrials.gov study NCT04975919. IPD Sharing: Not stated. Countries: 1. Publications: 0.
VOB560-MIK665 Combination First in Human Trial in Patients With Hematological Malignancies (Relapsed/Refractory Non-Hodgkin Lymphoma, Relapsed/Refractory Acute Myeloid Leukemia, or Relapsed/Refractory
ClinicalTrials.gov study NCT04702425. IPD Sharing: NO. Countries: 9. Publications: 0.
Vorinostat and Decitabine in Treating Patients With Advanced Solid Tumors or Relapsed or Refractory Non-Hodgkin's Lymphoma, Acute Myeloid Leukemia, Acute Lymphocytic Leukemia, or Chronic Myelogenous L
ClinicalTrials.gov study NCT00275080. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Observational Study on APL-like aCute Myeloid Leukemia: disTInct Phenotype and Early VAscular complicaTions
ClinicalTrials.gov study NCT07080970. IPD Sharing: Not stated. Countries: 0. Publications: 0.
Study of Liposomal Annamycin in Combination With Cytarabine for the Treatment of Subjects With Acute Myeloid Leukemia (AML)
ClinicalTrials.gov study NCT05319587. IPD Sharing: Not stated. Countries: 2. Publications: 0.
Cladribine Plus Homoharringtonine and Cytarabine Regimen (CHA) for de Novo Acute Myeloid Leukemia
ClinicalTrials.gov study NCT05906914. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Combination Merestinib and LY2874455 for Patients With Relapsed or Refractory Acute Myeloid Leukemia
ClinicalTrials.gov study NCT03125239. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Phase 1 Study of WU-NK-101 in Patients With Relapsed or Refractory (R/R) Acute Myeloid Leukemia (AML)
ClinicalTrials.gov study NCT05470140. IPD Sharing: Not stated. Countries: 2. Publications: 0.
CC-486 and Venetoclax for Acute Myeloid Leukemia
ClinicalTrials.gov study NCT05287568. IPD Sharing: NO. Countries: 1. Publications: 0.
A Study to Assess Change in Disease State in Adult Participants With Acute Myeloid Leukemia (AML) Ineligible for Intensive Chemotherapy Receiving Oral Venetoclax Tablets in Greece
ClinicalTrials.gov study NCT05317494. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
Treosulfan-Based Versus Clofarabine-Based Conditioning Before Donor Hematopoietic Stem Cell Transplant for the Treatment of Myelodysplastic Syndromes or Acute Myeloid Leukemia
ClinicalTrials.gov study NCT04994808. IPD Sharing: NO. Countries: 1. Publications: 0.
A Phase 1b/2 Open-label, Dose-ranging Safety and Efficacy Study of Oral Cladribine in Patients With Acute Myeloid Leukemia (AML)
ClinicalTrials.gov study NCT07053020. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Phase I Clinical Study: BG1805 Injection in the Treatment of Relapsed or Refractory Acute Myeloid Leukemia
ClinicalTrials.gov study NCT06118788. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Study Comparing Allogeneic Hematopoietic Cell Transplantation Versus Best Available Standard of Care Therapy in Elderly Patients With Acute Myeloid Leukemia
ClinicalTrials.gov study NCT04822766. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
Entinostat and Sorafenib Tosylate in Treating Patients With Advanced or Metastatic Solid Tumors or Refractory or Relapsed Acute Myeloid Leukemia
ClinicalTrials.gov study NCT01159301. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Study of Clofarabine in Japanese Patients With Acute Myeloid Leukemia (AML)
ClinicalTrials.gov study NCT01090167. IPD Sharing: Not stated. Countries: 1. Publications: 0.
An Early Phase Study of NEI-01 in Patients With Solid Tumors or Acute Myeloid Leukemia
ClinicalTrials.gov study NCT05226468. IPD Sharing: Not stated. Countries: 1. Publications: 0.
The Role and Mechanism of TCR-T Cells in Immunotherapy for Acute Myeloid Leukemia
ClinicalTrials.gov study NCT06904859. IPD Sharing: NO. Countries: 1. Publications: 0.
Individualized Induction Therapy for Non-elderly Acute Myeloid Leukemia Patients With Adverse Risk Features
ClinicalTrials.gov study NCT04752527. IPD Sharing: Not stated. Countries: 1. Publications: 0.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.